News
-
Glucose-lowering code in the gut: How do microbiota-bile acids protect pancreatic β-cells
Type 1 diabetes mellitus (T1D) is an autoimmune disease, which is caused by the immune system mistakenly attacking pancreatic β cells, resulting in absolute insufficient insulin secretion, and patients need to rely on insulin injection for life. However, traditional treatment can only control blo...Learn more + -
A new approach to blood glucose management: How can POCT devices make diabetic lactation more secure
Lactation is a special transition period for women’s physiology and psychology, and the existence of diabetes mellitus brings serious challenges to maternal and child health management during this period. The traditional blood glucose monitoring model is difficult to meet the dynamic care n...Learn more + -
From “ex post remedy” to “ex ante prevention” : FMEA reshaped the management mode of POCT blood glucose monitoring
In the diagnosis and treatment system of diabetes, Point-of-Care Testing (POCT) glucose meter has become the core tool for clinical blood glucose monitoring with its advantages of fast and convenient. However, the dispersion of POCT testing scenarios, the diversity of operators, and the complexit...Learn more + -
Sejoy 2026 Spring Festival Holiday Notice for the Year of the Horse: A New Journey Begins with the spirit of the dragon and the Horse, and a win-win future is created together
As the spring returns and the New Year begins, As the 2026 Lunar New Year of the Horse approaches, all the staff of Sejoy extend our most sincere New Year greetings to you and your family! May you be full of vigor and vitality, have a prosperous career, enjoy a happy family and all the best in th...Learn more + -
A study involving 800,000 people found: Your blood glucose control plan might be wrong!
In the clinical management of diabetes, we are accustomed to a “one-size-fits-all” blood sugar control model: all patients follow the same blood sugar control target and use similar treatment plans. However, this model neglects the individual differences among diabetic patients and of...Learn more + -
Beyond the dichotomy: LADA, a diabetes spectrum that straddles between type 1 and type 2
In the diagnosis and treatment of diabetes, we are accustomed to the dichotomy of “either-or” : either type 1 diabetes (T1DM) or type 2 diabetes (T2DM). However, in clinical practice, there are always some cases that puzzle doctors: some adult patients who seem to have “type 2 d...Learn more + -
One in every three adults has a “sugar front” : a health tsunami that is spreading
When the number of global diabetes patients exceeded 537 million, a more concealed crisis was quietly spreading – prediabetes. According to data from the International Diabetes Federation (IDF), approximately 540 million adults worldwide are in a prediabetic state, a figure that is almost o...Learn more + -
When blood glucose becomes the “invisible killer” in the ICU: The race against time for precise monitoring
In the life-and-death race in the intensive care unit (ICU), blood glucose monitoring may seem ordinary, but it has become a key variable determining the prognosis of patients. Global data shows that for every 2mmol/L increase in blood sugar in critically ill patients, the mortality rate rises by...Learn more + -
Are you a “healthy fat person” or a “metabolically abnormal thin person”? New criteria for diagnosing obesity
When the number on the scale can no longer define “fat people”, the intervention for obesity will also become more scientific. In January 2025, a significant report published in The Lancet Diabetes & Endocrinology completely overturned the obesity diagnosis system that had persis...Learn more + -
When Dialysis Meets Hypoglycemia: A Practical Guide to BGM Blood Glucose Management
In the clinical management of maintenance hemodialysis (MHD) patients, hypoglycemia is becoming an “invisible killer” that threatens lives. Data shows that the incidence of hypoglycemia among hemodialysis patients is as high as 40.62%, with diabetic nephropathy patients being particul...Learn more + -
When Red Blood Cells “Lie” : How to Break the Truth Value Dilemma of BGM Detection?
In the sophisticated system of diabetes management, blood glucose monitoring (BGM) serves as the core basis for guiding clinical decisions. However, when the number of red blood cells in the blood fluctuates, this seemingly simple detection process may fall into a “distortion predicament...Learn more + -
From “Abnormal Response” to “Risk Pre-positioning” : The Transformation Path of Perioperative Blood Glucose Monitoring in Non-Endocrinology Departments
Perioperative blood glucose fluctuations are a key factor affecting surgical safety and patient prognosis. Data shows that among non-endocrinology surgical patients, approximately 30% have stress-induced hyperglycemia, with over 60% having no history of diabetes. Uncontrolled hyperglycemia can in...Learn more +